Valuation : Indivior Pharmaceuticals, Inc.

Market Cap 4.12B 3.56B 3.34B 3.05B 5.73B 391B 5.77B 39.63B 15.39B 199B 15.48B 15.14B 660B P/E 2026 *
9.29x
P/E 2027 * 8.42x
Enterprise Value 4.11B 3.55B 3.33B 3.04B 5.71B 390B 5.75B 39.51B 15.35B 198B 15.43B 15.09B 658B EV / Sales 2026 *
3.09x
EV / Sales 2027 * 2.54x
Free-Float
97.98%
Yield 2026 *
-
Yield 2027 * -
1 week-2.58%
Current month+1.34%
1 week 29.8
Extreme 29.8
31
1 month 29.8
Extreme 29.8
34.2
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%-5.70% - - 4.12B
+0.28%-6.97%+58.34%+109.31% 1,031B
+2.01%-0.68%+53.07%+67.73% 641B
+1.39%-1.71%+23.57%+76.91% 453B
-1.50%-6.18%+33.50%+33.50% 349B
+6.25%+3.31%+29.46%+46.64% 290B
-0.07%-1.22%+1.46%+12.19% 252B
+1.92%-1.29%+52.28%+70.91% 232B
+0.51%-1.79%-18.09%-53.86% 201B
+2.45%+2.17%+32.71%+96.03% 181B
Average +1.54%-2.98%+29.59%+51.04% 403.31B
Weighted average by Cap. +1.41%-3.97%+38.53%+66.75%

Financials

2026 *2027 *
Net sales 1.33B 1.15B 1.08B 985M 1.85B 126B 1.86B 12.8B 4.97B 64.29B 5B 4.89B 213B 1.4B 1.21B 1.14B 1.04B 1.94B 133B 1.96B 13.45B 5.23B 67.55B 5.25B 5.14B 224B
Net income 474M 409M 385M 351M 659M 45.03B 664M 4.56B 1.77B 22.89B 1.78B 1.74B 75.95B 530M 457M 430M 392M 736M 50.32B 742M 5.09B 1.98B 25.58B 1.99B 1.95B 84.87B
Net Debt -12.5M -10.78M -10.14M -9.25M -17.37M -1.19B -17.49M -120M -46.68M -603M -46.93M -45.91M -2B -570M -492M -462M -422M -792M -54.12B -798M -5.48B -2.13B -27.51B -2.14B -2.09B -91.28B
Logo Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc. is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. It sells its products in the United States and in other selected areas of the world.
Employees
-
Date Price Change
01/09/26 €30.20 +1.34%
31/08/26 €29.80 -1.32%
28/08/26 €30.20 -1.31%
27/08/26 €30.60 -1.29%
26/08/26 €31.00 0.00%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
34.93USD
Average target price
49.00USD
Spread / Average Target
+40.28%

Quarterly revenue - Rate of surprise